| ID | Sequence | Length | GC content |
|---|---|---|---|
| GAAACAUUUGCUAGCCAGCUGAGUGACAGUGAUGGAUUCAAAACAUCAG… | 1186 nt | 0.4629 | |
| AAACAUUUGCUAGUCAGACAAGUGACAGGGAAUGGAUUCCAAACACCAG… | 1026 nt | 0.4035 | |
| AAACAUUUGCUAGUCAGACAAGUGACAGGGAAUGGAUUCCAAACACCAG… | 1186 nt | 0.4621 |
This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols by utilizing NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ), and the oxidation of 9alpha,11beta-PGF2 to PGD2. It may play an important role in the pathogenesis of allergic diseases such as asthma, and may also have a role in controlling cell growth and/or differentiation. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
A study in healthy young women using a monozygotic twin design demonstrated that mRNA expression of the AKR1C3 gene, an indicator of local androgen activation, was significantly higher in both whole adipose tissue and isolated adipocytes of heavier co-twins compared to their leaner sisters [Vihma et al. DOI:10.1016/j.steroids.2018.08.006]. In a separate human intervention study, the AKR1C3 gene was found to be downregulated in subcutaneous adipose tissue during short-term weight loss [Bollepalli et al. DOI:10.1038/ijo.2017.245].